Open Dialogue treatment model reduces out-of-home mental health care for adolescents

In a ten-year registry follow-up, adolescents treated according to the Open Dialogue treatment model had a lower risk of receiving out-of-home care compared to those receiving other forms of mental health treatment.

US FDA approves Amneal’s 505(b)(2) NDA for PEMRYDI RTU

PEMRYDI RTU will be offered in 500 mg/50mL, 100mg/10mL and 1,000mg/100mL vial sizes. Credit: MasterTux from Pixabay. The US Food and Drug Administration (FDA) has

June 15, 2023

Reports of telehealth’s death have been greatly exaggerated

“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering over virtual care.” These are just a few of the

May 21, 2024

‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to

March 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.